
The site is temporarily down due to maintenance. Sorry for the inconvenience.
The site is temporarily down due to maintenance. Sorry for the inconvenience.
Quality & Accuracy
Experience
The latest technologies
Speed &
Credibility
₾5,600.00
Material can be taken:
Samples are sent to Medicover Genetics' German laboratory.
Time to get results: 5-7 weeks from sample submission
Whole exome sequencing (WES) is a complex genetic test that analyzes the protein-coding regions of all human genes—or exons (~20,000 genes). The collection of all exons is called the exome.
85% of genomic variants associated with diseases are concentrated in the exome (coding regions of genes), while the remaining 15% are located in introns (non-coding regions of genes).
Whole exome sequencing (WES) includes three panels, which are:
Trio WES is the most commonly performed analysis, providing the most complete results and the highest diagnostic accuracy. Trio WES Allows all inheritance patterns to be analyzed simultaneously and the significance of clinically important variants to be determined.
If only one biological parent is present with the patient, Duo WES (patient+parent) can be performed.
If neither biological parent is present, Single WES is the only possible test.
Whole exome sequencing (WES) is performed primarily on patients with rare or unexplained symptoms, especially in children with neurodevelopmental disorders. It is also used in oncology, in the diagnostics of hereditary diseases, and when other tests fail to provide an answer:
In whole exome sequencing, the study results describe all pathogenic, conditionally pathogenic, and variants of unknown significance that may be associated with clinical manifestations.
Pathogenic and likely pathogenic variants: A genetic cause has been identified that is associated with the presenting symptoms and is important in determining the correct treatment and management plan.
Variants of uncertain significance: The identified variant cannot be classified as pathogenic or neutral, but may require additional research or testing of family members to determine its association with clinical manifestations.
Randomly discovered options: Genetic changes that are not related to the patient's current condition, but may affect the patient's health in the future.
Secondary findings: Genetic changes that are not related to the patient's current condition, but are intentionally tested for because of their impact on health. If a variant of interest is identified, the data is reflected in the report (even though it is unrelated to the patient's current condition).
A negative result does not mean the disease is absent or that a genetic cause of the disease has been completely ruled out. Sometimes additional testing is needed.
Whole exome sequencing (WES) allows for the analysis of many genes at once. This significantly increases the chance of discovering the genetic cause of a disease, especially when symptoms are complex and make diagnostics difficult. The genomic information obtained is important for assessing the risk of genetic transmission of existing variants.
technology
DNA is extracted from the sample and next-generation sequencing (NGS) is used to examine all coding regions (exons). The study reveals single-base changes, small deletions and duplications, and copy number variations. Variants are classified according to the ACMG guidelines (Richards et al. 2015, Genet Med 17:405; Kearney et al. 2011, Genet Med 13: 680).
Order tests online
Other tests
Testing process
| Purchase a test | Submission of material |
| Results Online | Consult a doctor |
